Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, pso...

por Burmester, Gerd R, Panaccione, Remo, Gordon, Kenneth B, McIlraith, Melissa J, Lacerda, Ana P M
Publicado 2013